(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Cardiovascular diseases account for about half of total mortality in industrialised societies. This figure has declined only slightly and in few countries over the past few decades, which is disturbing in view of our increasing insight into long-term risk factors of coronary heart disease and the dramatic improvement in the acute therapy of its manifestations. One important reason for this is the high fatality during the initial hours of a coronary event, i.e. before medical treatment can be provided. Approximately one quarter of all patients suffering an acute cardiac event die prior to admission to hospital.
As a result, the focus of current research has shifted from after-the-fact therapy to the triggering phase of acute coronary disease. Epidemiological observations of recent trends and newly identified determinants of coronary disease and the results of substantial pathophysiological studies of the conversion from chronic coronary disease to an acute event provide the basis for new hypotheses about the triggering mechanisms. The ultimate goal is to design more effective preventive strategies for these deadly diseases.
The present extensive summary of important scientific and clinical developments in the study of the triggering and prevention of coronary syndromes that have been seen over the last ten years contains the contributions of leading experts in the field. It presents a cooperative, balanced view derived from physicians and researchers in the U.S. and Europe.
Contents:
Foreword; E. Braunwald. Introduction; S.N. Willich, J.E. Muller. Part one: Epidemiology. Magnitude of cardiovascular disease: impact and prevention in populations; D.E. Bild, L. Friedman. Secular trends and declining mortality rates from coronary heart disease in the United States; R.J. Goldberg. Circadian variation in the incidence of transient myocardial ischemia; D. Mulcahy, H. Purcell. Circadian variation in the onset of myocardial infarction and sudden cardiac death; J.E. Muller, S.N. Willich. Triggering of myocardial infarction by physical activity, emotional stress and sexual activity; M.A. Mittelman. Physical activity, time of awakening, and other possible triggers of sudden cardiac death; S.N. Willich, et al. Subacute psychobiological factors predisposing to triggering of coronary syndromes; S. Wassertheil-Smoller. Part two: Physiology. The genetic contribution to the onset of acute coronary heart disease; F. Cambien, et al. Hemostatic risk factors for cardiovascular disease; P.P. Jadhav, G.H. Tofler. The imbalance of coagulation and fibrinolysis in coronary heart disease and its known risk factors; K. Winther, et al. Mechanisms contributing to the abrupt conversion from stable to unstable angina and myocardial infarction; J.T. Willerson. Circadian fluctuation of fibrinolytic factors in blood. Investigation, importance and clinical consequences; F. Andreotti, A. Manzoli. The role of thrombosis in acute coronary heart disease; A. Fernandez-Ortiz, V. Fuster. The role of coronary vasomotor tone in coronary artery disease; A.A. Quyyumi. Part three: Pathology. Models of the intracoronary pathogenesis of acute coronary heart disease; J.P. Liang, et al. Some thoughts on the causes ofcoronary thrombosis in atherosclerotic arteries and on the research necessary for their future exploration; P. Constantinides. Determinants of rupture of atherosclerotic coronary lesions; P.R. Moreno, et al. Part four: Prevention. Primary prevention of triggering of coronary heart disease; I.S. Ockene. Chronopharmacological aspects of coronary heart disease; B. Lemmer, K. Witte. Prehospital care of acute coronary heart disease; H.-R. Arntz, et al. Pharmacological and invasive therapy for acute myocardial infarction; R. Schroeder. The role of electrophysiology and pharmacotherapy in prevention of factors triggering sudden cardiac death; R. Haberl, et al. Secondary prevention of myocardial infarction; the roles of -adrenergic blockers, calcium-channel blockers, angiotensin converting enzyme inhibitors, and aspirin; W.H. Frishman. Gene therapy for the vulnerable atherosclerotic plaque; L.J. Feldman, J.M. Isner. Index.
PRODUCT DETAILS
Publisher: Springer
Publication date: September, 2011
Pages: 424
Weight: 717g
Availability: Available
Subcategories: Cardiovascular Medicine
From the same series
Jean-Claude Tardif
Xander H T Wehrens
Johan H. C. Reiber
Raimund Erbel
M.P. Sambhi
Pedro Brugada
W. Bleifeld
Naranjan S. Dhalla
Bohuslav Ostadal
Ralph Shabetai
Jason X.-J. Yuan
Hein J.J. Wellens
R. C. Becker
Franz H. Messerli
C.H. Peels
Stephen M. Factor
Hiroyuki Suga
Hugo Ector
Brian E. Jaski
Richard A. Walsh
Seymour Glagov
Michiel J. Janse
Lloyd W. Klein
Thomas H Marwick
Ernst E. van der Wall
P.J. Walter
Ernst E. van der Wall
Ernst E. van der Wall
A-M. Salmasi
Michel Emile Safar
A-M. Salmasi
Ernst E. van der Wall
Andrea Natale
Albert de Roos
C.A. Nienaber
Guillem Pons-Llado
Vinzenz Hombach
R. Vos
J. Candell-Riera
R.W. Stout
Peter Hanrath
Johan H. C. Reiber
P.A.F.M. Doevendans
Jack Rychik
P.A.F.M. Doevendans
P.E. Vardas
Makoto Nagano
George D. Dangas
Myrvin H. Ellestad
C.J. Preusse
Thomas H Marwick
Thomas H Marwick
Ernst E. van der Wall
G.T. Meester
A.G. Herman
J.C. Tardif
P.J. Walter
Johan H. C. Reiber
Ernst E. van der Wall
Lloyd W. Klein
Akira Matsumori
Robert L. Wilensky
Bernard Swynghedauw
Juan Carlos Kaski
Franz H. Messerli
John F. Keaney Jr.
Keith L. March
Naranjan S. Dhalla
Zainul Abedin
Juan Carlos Kaski
Eric J Topol
A.V. Bruschke
Richard C. Becker
J. Candell-Riera
Ghassan Bkaily
Lionel H. Opie
Bernard Swynghedauw
Geoffrey Burnstock
P. Cummins
Nicholas Sperelakis
Mina Rajskina
A.A. Knowlton
Johan H. C. Reiber
Irene D. Turpie
J. A. E. Spaan
Ernst E. van der Wall
Masatsugu Hori
Bing Liem Liong
R. Fagard
M. Iwase
R. Stroobandt
A.V. Bruschke
David M. Mirvis
Franz H. Messerli
G. Assmann
Melvin Scheinman
J. Morganroth
J.W. de Jong
M.B. Rosenbaum
C. Tissa Kappagoda
H.V. Villareal
J. Morganroth
Ernst E. van der Wall
Naranjan S. Dhalla
H. Mitchell Perry Jr.
M.P. Spencer
Henk Keurs
C.T. Lancée
J.R. Roelandt
G.S. Wagner
H. Kesteloot
A.C. Arntzenius
Johan H. C. Reiber
A. Maseri
Michel Emile Safar
M.P. Spencer
W. Bleifeld
Henk Keurs
Willem H. Birkenhager
Antonio Bayes de Luna
J.R. Roelandt
Naranjan S. Dhalla
H. Rijsterborgh
Marianne J. Legato
Naranjan S. Dhalla
S. Chien
Rafael Beyar
H.E. Van Dam
M.P. Spencer
J.R. Roelandt
Hilbert J.Th. Thalen
C. Marchesi
J.P.M Hamer
Rafael Beyar
L.N. Bouman
A. Alboni
Douglas P. Zipes
Nicholas Sperelakis
Borys Surawicz
Antonio Bayes de Luna
Johan H. C. Reiber
Hein J.J. Wellens
J.V. Chapman
E. Aliot
Vinzenz Hombach
Michael R. Rosen
William H. Gaasch
Pawan K. Singal
Robert Plonsey
H.L. Stone
J. Soler-Soler
Ernst E. van der Wall
Michel Emile Safar
J. Morganroth
Hein J.J. Wellens
J.R. Roelandt
Vinzenz Hombach
Richard S. Meltzer
Marvin A. Konstam
Naranjan S. Dhalla
Naranjan S. Dhalla
Johan H. C. Reiber
C.A. Nienaber
Ernst E. van der Wall
Robert J. Siegel
Markus Schwaiger
Andrew Wechsler
Elliot Rapaport
Naranjan S. Dhalla
John E. Tooke
Derek Yellon
Henk Keurs
Steve M. Teague
J.W. de Jong
Naranjan S. Dhalla
Nicholas Sperelakis
P.H. Heintzen
J. Morganroth
John B. Lombardini
Adam Schneeweiss
J.R. Roelandt
Naranjan S. Dhalla
Naranjan S. Dhalla
J.C. Chatham
Pim J. de Feyter
David W. Holt
Catherine A. Neill
J. Roelandt
A.P. Shepherd
Gastone Leonetti
Nico H.J. Pijls
K. Robinson
P.A.F.M. Doevendans
Douglas P. Zipes
Jose Marin-Garcia
Jonathan S. Steinberg
Francisco Villarreal
Dick Macdonald
Ragavendra R. Baliga
Dick Macdonald